Grant Detail
This is a chronological listing of grants held by this department, with the most recent listed first. New grants appear in this list weekly and contribute related to the department's Research Profile. The source of grants for this application comes directly from your institution.
00101/Autism A Phase III Randomized Double Blind Placebo Controlled Trial of L
Linmarie Sikich; Cheryl Alderman; Madeline Puglia
11/2/2009 - 11/1/2012| Sponsoring Organization: | Industry Sponsor |
| Awarding Organization Is: | University of North Carolina at Chapel Hill |
| Funding: | $ 6,720.00 |
Linmarie Sikich (Lead Principal Investigator)
This is a phase III randomized double-blind placebo-controlled study evaluating the efficacy and safety of Luminenz-AT (CM-AT) in pediatric patients with autism.
